Aspergillus endocarditis after cardiac surgery

Area of Science:

• Infectious Diseases
• Cardiology
• Mycology

Background:

• Aspergillus species infections are increasingly prevalent in hospital settings.
• Aspergillus endocarditis is a severe manifestation with a poor prognosis, particularly in cardiac surgery patients.
• Risk factors include valvular issues, indwelling catheters, prolonged antibiotic use, malignancy, and intravenous drug use.

Purpose of the Study:

• To review the current literature on fungal and Aspergillus endocarditis.
• To identify risk factors, clinical presentations, and therapeutic strategies for Aspergillus endocarditis.
• To emphasize the critical need for early diagnosis and intervention.

Main Methods:

• A comprehensive review of existing literature on fungal and Aspergillus endocarditis was conducted.
• Key aspects examined include risk factors, clinical manifestations, diagnostic challenges, and treatment modalities.
• Emphasis was placed on outcomes in post-cardiac surgery patients.

Main Results:

• Clinical presentation is often insidious, with embolic events frequently being the initial sign.
• Blood cultures are typically negative, complicating diagnosis.
• The mortality rate approaches 100% without timely and aggressive treatment.

Conclusions:

• Aspergillus endocarditis is a grave complication following cardiac surgery.
• Amphotericin B is the primary medical treatment, often supplemented with other therapies.
• Prompt surgical intervention upon diagnosis is essential and can improve the dismal prognosis.